A clinical trial to study the effect of the drug tranexamic acid in reducing seroma after mastectomy in breast cancer patients.
Phase 3
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/10/058691
- Lead Sponsor
- AIIMS Raipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of breast cancer undergoing mastectomy with axillary clearance irrespective of tumor stage.
2.Patients aged > 18 years
Exclusion Criteria
1.Patients with history of pre-operative breast/axillary irradiation.
2.Patients with history of seizures, cerebrovascular ischemia
3.Male patients
4.History of prior ipsilateral breast or axillary surgery for any indication
5.Patients undergoing bilateral axillary dissection
6.Patients with known history of reaction to tranexamic acid.
7.Patients with any coagulation disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of seroma formationTimepoint: Daily from first post operative days till discharge. Follow up in OPD after discharge on day 07 , 14 , 30
- Secondary Outcome Measures
Name Time Method oneTimepoint: Not applicable